FeesSafety
Pluang+

Cardinal Energy posts strong Q3 cash flow, supports dividend with SAGD project boosting production.

Market News
18 Nov 2026, 17:30 WIB
Seeking Alpha
View Source
Bullish
Cardinal Energy posts strong Q3 cash flow, supports dividend with SAGD project boosting production.

Cardinal Energy reported a strong Q3 with normalized free cash flow of about C$56 million, well above its C$32 million quarterly dividend. The company’s SAGD thermal oil project, Reford 2, is expanding to 6,000 barrels per day and is expected to push production above 30,000 BOE/day by 2027. This low-cost production remains profitable even if oil prices drop to US$50 per barrel, supporting a favorable risk/reward profile. The company’s clean balance sheet and robust production outlook make it appealing after recent market corrections.

Cardinal Energy's recent performance provides context for energy market activity on Pluang. For readers following energy stocks, here is Pluang's market snapshot as of Nov 18, 2026 19:52 WIB: Among 79 priced Energy-sector US stocks, 21 rose and 55 fell today. Notable quotes include Permian Resources Corporation Class A Common Stock (PR) at USD 21.85 with a 1-day change of -1.49% and Pluang order activity showing 0% Sell / 100% Buy, Kosmos Energy Ltd. Common Shares (DE) (KOS) at USD 2.00 with a 1-day change of -1.48%, and Eni SpA (E) at USD 55.55 with a 1-day change of -1.45%. Typical hold times on Pluang range from 4 to 56 days for these stocks.

More News

Global pharmaceutical market to hit $3.2T by 2035, led by obesity and cancer drug growth amid US tariff shifts

Global pharmaceutical market to hit $3.2T by 2035, led by obesity and cancer drug growth amid US tariff shifts

The global pharmaceutical market is projected to grow from $1.88 trillion in 2026 to $3.20 trillion by 2035, driven mainly by obesity and oncology drugs. The U.S. market, holding 42% of the global share, faces new tariffs linked to pricing deals and ...

Bullish
53 minutes ago
LEQEMBI slows Alzheimer's progression by 76% over 3 years in real-world study of 560 patients.

LEQEMBI slows Alzheimer's progression by 76% over 3 years in real-world study of 560 patients.

A new three-year real-world study of 560 early Alzheimer's patients treated with LEQEMBI showed a 76% reduction in progression to moderate or severe dementia compared to a matched control group. Over 81% of patients remained stable or improved after ...

Market News
Bullish
53 minutes ago
Fox Factory wins seventh straight Baja 1000 and sweeps 2026 SCORE off-road championships

Fox Factory wins seventh straight Baja 1000 and sweeps 2026 SCORE off-road championships

Fox Factory Holding Corp. celebrated its seventh consecutive overall victory at the 2026 SCORE Baja 1000, with FOX Shocks and Method Race Wheels powering the winning team. The company’s equipment helped athletes sweep all four 2026 SCORE Internationa...

Market News
Bullish
53 minutes ago
Global automotive actuators market to grow to $40.3B by 2033 driven by electrification and automation

Global automotive actuators market to grow to $40.3B by 2033 driven by electrification and automation

The global automotive actuators market, valued at $29.3 billion in 2025, is projected to grow to $40.3 billion by 2033 at a CAGR of 4.4%. Growth is fueled by rising electric vehicle production, advanced safety systems, and automation technologies. As...

Market News
Bullish
53 minutes ago
TJX Companies beats Q3 sales estimates; shares jump 10% on strong international growth and holiday optimism.

TJX Companies beats Q3 sales estimates; shares jump 10% on strong international growth and holiday optimism.

The TJX Companies reported Q3 FY2027 revenue of $16 billion, beating estimates with a 5.5-6% year-over-year increase. Comparable store sales grew 4%, led by strong international segment performance, while the domestic Marmaxx group showed slower grow...

Company Fundamentals
Bullish
56 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App